Alzheimer's drugs linked to lower death, heart attack risk

06/5/2013 | MedPage Today (free registration)

Alzheimer's disease patients who took cholinesterase inhibitors to improve cognitive function were 34% less likely to die and experience myocardial infarction than non-users, researchers found. The risk of myocardial infarction was lowest among those who took the highest doses. The study, based on data from more than 7,000 patients in Sweden, was published in the European Heart Journal.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN